Latest filing published 04 Feb 2014 for INVITROGEN CORP, €465k.
No signal scores available.
John A. Cottingham is a declared insider of Invitrogen Corp, with filings sourced from SEC (Form 4). We count 78 filings; the first trade dates from 14 May 2007 and the latest from 3 February 2014.
No open-market purchase appears, only 20 sales worth €10.5M. The rest of the record consists of 25 share grants and 30 option exercises.
Most recently, on 4 February 2014, the filings show a transaction worth €465k in Invitrogen Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 73 declarations